Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EPHA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ANAPC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP2K7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC110 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPM1H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MINOS1-NBL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MYO10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506207 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
EIF2B3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC167 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC14L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCTS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMX1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on